跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ABIRATERONA KRKA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
ABIRATERONA KRKA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 4, 2021
Approval ID
3aa5dd2a5574ca58
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
3aa5dd2a5574ca58
Drug Cima Aemps Name
ABIRATERONA KRKA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
1211553002
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2021-08-04
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
500 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Krka D.D. Novo Mesto
Active Ingredients
ABIRATERONA ACETATO
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 4, 2021
Approval ID
3aa5dd2a5574ca58
Type
Standard
Back to CIMA-AEMPS Approvals
ABIRATERONA KRKA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
